# COQ6

## Overview
The COQ6 gene encodes a flavin-dependent monooxygenase enzyme that plays a pivotal role in the biosynthesis of coenzyme Q10 (CoQ10), a crucial component of the mitochondrial electron transport chain. This enzyme is categorized as a monooxygenase due to its function in catalyzing the hydroxylation of the benzoquinone ring, a key step in CoQ10 production. The COQ6 protein is localized in the mitochondria, where it forms part of a multienzymatic complex essential for CoQ10 biosynthesis, contributing to cellular energy production and acting as an antioxidant. Mutations in the COQ6 gene can lead to CoQ10 deficiencies, resulting in severe disorders such as steroid-resistant nephrotic syndrome and sensorineural deafness, underscoring the gene's significance in maintaining mitochondrial function and overall cellular health (Doimo2014Effect; Laredj2014The; Heeringa2011COQ6).

## Structure
The COQ6 gene encodes a flavin-dependent monooxygenase involved in the biosynthesis of coenzyme Q10 (CoQ10), essential for mitochondrial function. The COQ6 protein is predicted to be expressed in mitochondria and has a molecular weight of approximately 54 kDa for isoform a, which includes a mitochondrial leader peptide, and 51 kDa for isoform b (Heeringa2011COQ6). The protein contains 12 exons and is highly conserved across species, with significant sequence identity to orthologs in other organisms (Heeringa2011COQ6).

The COQ6 protein includes three flavin adenine dinucleotide (FAD)-binding motifs, crucial for its enzymatic activity, suggesting a specific secondary structure necessary for binding FAD, a cofactor involved in redox reactions (Heeringa2011COQ6). The structure of human COQ6 is modeled on Pseudomonas fluorescens para-hydroxybenzoate hydroxylase, focusing on residues Y412 and A353, which interact with the Rossman fold involved in FAD binding (Doimo2014Effect). The substrate prenyl-4HB binds in a pocket similar to that in pHBH, with G255 located in the active site pocket (Doimo2014Effect).

The COQ6 protein is part of a multienzymatic complex located on the mitochondrial inner membrane, involved in CoQ biosynthesis (Doimo2014Effect). The protein's function as a monooxygenase suggests it may form a complex with other proteins involved in CoQ10 biosynthesis, although specific quaternary structure details are not mentioned (Heeringa2011COQ6).

## Function
The COQ6 gene encodes a flavin-dependent monooxygenase enzyme that plays a critical role in the biosynthesis of coenzyme Q10 (CoQ10), also known as ubiquinone. CoQ10 is an essential component of the mitochondrial electron transport chain, where it functions as an electron transporter between complexes I and II and complex III, facilitating ATP production (Laredj2014The; Heeringa2011COQ6). The COQ6 enzyme specifically catalyzes the hydroxylation of the C5 position of the benzoquinone ring, a crucial step in the CoQ10 biosynthesis pathway (Laredj2014The).

In healthy human cells, COQ6 is primarily localized in the mitochondria, where it contributes to cellular energy production and acts as a lipid-soluble antioxidant, protecting cells from damage by reactive oxygen species (ROS) (Yen2020Characterization; Heeringa2011COQ6). The enzyme's activity is vital for maintaining the integrity of the mitochondrial respiratory chain and overall cellular energy metabolism (Laredj2014The). Mutations in COQ6 can lead to CoQ10 deficiencies, which are associated with various severe disorders, highlighting the gene's importance in cellular and organismal health (Heeringa2011COQ6).

## Clinical Significance
Mutations in the COQ6 gene are associated with several severe conditions, primarily steroid-resistant nephrotic syndrome (SRNS) and sensorineural deafness (SND). These mutations can lead to early-onset nephrotic syndrome characterized by proteinuria, which often progresses to end-stage renal failure (ESRF) at a young age. Patients may also experience additional symptoms such as seizures, white matter abnormalities, ataxia, and facial dysmorphism (Wang2022A; Heeringa2011COQ6). 

COQ6 mutations are linked to primary coenzyme Q10 deficiency-6 (COQ10D6), a rare autosomal recessive disorder. This condition is characterized by severe progressive infantile-onset nephrotic syndrome and sensorineural hearing loss (Wang2022A). The COQ6 gene mutations can also result in optic atrophy, as observed in some patients (Justine2020COQ6). 

Treatment with coenzyme Q10 (CoQ10) has shown potential benefits in some cases, as CoQ10 supplementation can partially reverse the effects of COQ6 knockdown in podocytes and improve symptoms in patients (Stańczyk2018CoQ10related; Heeringa2011COQ6). However, the effectiveness of CoQ10 treatment may vary depending on the severity of the condition and the extent of organ damage (Wang2022A).

## Interactions
The COQ6 protein is a flavin-dependent monooxygenase involved in the biosynthesis of coenzyme Q10. It participates in a multiprotein complex with other COQ proteins, including COQ3, COQ4, COQ5, COQ7, and COQ9, which are essential for coenzyme Q production. COQ6 has been shown to physically interact with COQ9, as evidenced by co-precipitation experiments in yeast models (Hsieh2007Saccharomyces; Subramanian2019Coenzyme). These interactions suggest that COQ6 is part of a network of proteins that form a complex to enhance catalytic efficiency and prevent the release of reactive intermediates during coenzyme Q biosynthesis (Hsieh2007Saccharomyces).

In human cells, COQ6 is localized in the mitochondria and is part of high-molecular-mass protein complexes that include COQ3, COQ4, COQ5, COQ7, and COQ9, as well as PDSS2, which are involved in maintaining coenzyme Q10 levels (Yen2020Characterization). The interaction between COQ6 and COQ3 is particularly notable, as the knockdown of COQ6 results in a significant reduction of COQ3 levels, indicating a potential dependency or regulatory relationship between these proteins (Yen2020Characterization).


## References


[1. (Doimo2014Effect) Mara Doimo, Eva Trevisson, Rannar Airik, Marc Bergdoll, Carlos Santos-Ocaña, Friedhelm Hildebrandt, Placido Navas, Fabien Pierrel, and Leonardo Salviati. Effect of vanillic acid on coq6 mutants identified in patients with coenzyme q10 deficiency. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1842(1):1–6, January 2014. URL: http://dx.doi.org/10.1016/j.bbadis.2013.10.007, doi:10.1016/j.bbadis.2013.10.007. This article has 63 citations.](https://doi.org/10.1016/j.bbadis.2013.10.007)

[2. (Yen2020Characterization) Hsiu-Chuan Yen, Wen-Yu Yeh, Szu-Hsien Lee, Yu-Hsiu Feng, and Si-Ling Yang. Characterization of human mitochondrial pdss and coq proteins and their roles in maintaining coenzyme q10 levels and each other’s stability. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1861(7):148192, July 2020. URL: http://dx.doi.org/10.1016/j.bbabio.2020.148192, doi:10.1016/j.bbabio.2020.148192. This article has 17 citations.](https://doi.org/10.1016/j.bbabio.2020.148192)

[3. (Hsieh2007Saccharomyces) Edward J. Hsieh, Peter Gin, Melissa Gulmezian, UyenPhuong C. Tran, Ryoichi Saiki, Beth N. Marbois, and Catherine F. Clarke. Saccharomyces cerevisiae coq9 polypeptide is a subunit of the mitochondrial coenzyme q biosynthetic complex. Archives of Biochemistry and Biophysics, 463(1):19–26, July 2007. URL: http://dx.doi.org/10.1016/j.abb.2007.02.016, doi:10.1016/j.abb.2007.02.016. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2007.02.016)

[4. (Subramanian2019Coenzyme) Kelly Subramanian, Adam Jochem, Maxence Le Vasseur, Samantha Lewis, Brett R. Paulson, Thiruchelvi R. Reddy, Jason D. Russell, Joshua J. Coon, David J. Pagliarini, and Jodi Nunnari. Coenzyme q biosynthetic proteins assemble in a substrate-dependent manner into domains at er–mitochondria contacts. Journal of Cell Biology, 218(4):1353–1369, January 2019. URL: http://dx.doi.org/10.1083/jcb.201808044, doi:10.1083/jcb.201808044. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201808044)

[5. (Heeringa2011COQ6) Saskia F. Heeringa, Gil Chernin, Moumita Chaki, Weibin Zhou, Alexis J. Sloan, Ziming Ji, Letian X. Xie, Leonardo Salviati, Toby W. Hurd, Virginia Vega-Warner, Paul D. Killen, Yehoash Raphael, Shazia Ashraf, Bugsu Ovunc, Dominik S. Schoeb, Heather M. McLaughlin, Rannar Airik, Christopher N. Vlangos, Rasheed Gbadegesin, Bernward Hinkes, Pawaree Saisawat, Eva Trevisson, Mara Doimo, Alberto Casarin, Vanessa Pertegato, Gianpietro Giorgi, Holger Prokisch, Agnès Rötig, Gudrun Nürnberg, Christian Becker, Su Wang, Fatih Ozaltin, Rezan Topaloglu, Aysin Bakkaloglu, Sevcan A. Bakkaloglu, Dominik Müller, Antje Beissert, Sevgi Mir, Afig Berdeli, Seza ϖzen, Martin Zenker, Verena Matejas, Carlos Santos-Ocaña, Placido Navas, Takehiro Kusakabe, Andreas Kispert, Sema Akman, Neveen A. Soliman, Stefanie Krick, Peter Mundel, Jochen Reiser, Peter Nürnberg, Catherine F. Clarke, Roger C. Wiggins, Christian Faul, and Friedhelm Hildebrandt. Coq6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. Journal of Clinical Investigation, 121(5):2013–2024, May 2011. URL: http://dx.doi.org/10.1172/jci45693, doi:10.1172/jci45693. This article has 328 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci45693)

[6. (Wang2022A) Na Wang, Youmin Zheng, Lingzi Zhang, Xiong Tian, Yicheng Fang, Ming Qi, Juping Du, Shuaishuai Chen, Shiyong Chen, Jun Li, Bo Shen, and Lizhen Wang. A family segregating lethal primary coenzyme q10 deficiency due to two novel coq6 variants. Frontiers in Genetics, January 2022. URL: http://dx.doi.org/10.3389/fgene.2021.811833, doi:10.3389/fgene.2021.811833. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.811833)

[7. (Justine2020COQ6) R. Justine Perrin, Caroline Rousset‐Rouvière, Florentine Garaix, Aline Cano, John Conrath, Olivia Boyer, and Michel Tsimaratos. Coq6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy. JIMD Reports, 54(1):37–44, May 2020. URL: http://dx.doi.org/10.1002/jmd2.12068, doi:10.1002/jmd2.12068. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jmd2.12068)

[8. (Stańczyk2018CoQ10related) Małgorzata Stańczyk, Irena Bałasz-Chmielewska, Beata Lipska-Ziętkiewicz, and Marcin Tkaczyk. Coq10-related sustained remission of proteinuria in a child with coq6 glomerulopathy—a case report. Pediatric Nephrology, 33(12):2383–2387, September 2018. URL: http://dx.doi.org/10.1007/s00467-018-4083-3, doi:10.1007/s00467-018-4083-3. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00467-018-4083-3)

[9. (Laredj2014The) Leila N. Laredj, Floriana Licitra, and Hélène M. Puccio. The molecular genetics of coenzyme q biosynthesis in health and disease. Biochimie, 100:78–87, May 2014. URL: http://dx.doi.org/10.1016/j.biochi.2013.12.006, doi:10.1016/j.biochi.2013.12.006. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2013.12.006)